Additionally, several preclinical studies suggest that the blockade of IL-1β through anti-IL-1β or neutralizing antibodies attenuate inflammatory responses, brain tissue loss, and cognitive deficits following TBI in mice [48,49,50]. Here, IL1B is linked to Cognitive impairment.